Finch Therapeutics Raises $36 Million Series B, Bringing Total to $77 Million Post author:Sam Post published:February 28, 2018 Post category:BioPharma Finch Therapeutics closed on an oversubscribed Series B financing worth $36 million. Source: BioSpace You Might Also Like Celgene Stocks Up on More Juno Stock After Failed Flagship Drug Trial March 28, 2017 AI Firm Exscientia Grabs EUR250 Million Small Molecules Pact With Sanofi May 8, 2017 Despite Expansion Overall, Roche Diabetes Care Lays Off 157 March 14, 2017
